Looking at the list of catalysts and summary of the drugs -- any one of those drugs progressing into Phase 3 trials ought to value this stock at a MINIMUM of double the current price.

Let's be conservative and say that only 2 of those drugs work -- think about what the share price would be, if the efficient market theory were correct (which we've established, it's not)

I will be gone a lot today -- hope you guys can keep posting any observations about share price movement if you're watching Level 2 or just bid/ask/last trade weirdnesses.